Primary industry: Biotechnology | Secondary industry: Consulting
A seasoned Theoretical Information Physicist and Computational Biophysicist with over 15 years of experience driving innovation in computational biology and computer-aided drug discovery (CADD).
He co-founded Proholistic Discovery, leveraging Inference AI to deliver advanced ADMET and Physiologically Based Pharmacokinetic/Pharmacodynamic (PBPK/PD) modeling services.
Previously, he led a computational group, specializing in the development of a Quantitative Systems Pharmacology (QSP) platform for combination drug discovery. His leadership steered PK/PD modeling and simulation across key projects, including Long COVID, hepatocarcinoma, and anti-aging treatments.
An inventor with eight patents/invention reports, he also pioneered a computational tool for designing therapeutic and diagnostic short oligonucleotides. He has authored 30+ peer-reviewed publications and book chapters.
Core Expertise: Inference AI, QSP, CADD, PBPK/PD Modeling, Computational Biology, Oligonucleotide Design.